DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension ...

Retrieved on: 2024-06-10 17:35:55

Tags for this article:

Click the tags to see associated articles and topics

DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension .... View article details on hiswai:

Excerpt

SEOUL, South Korea, June 10, 2024 /PRNewswire/ -- DeepQure, a Seoul based medical device company with a novel, extravascular (laparoscopic ...

Article found on: www.fox44news.com